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ABSTRACT
The splicing factor Transformer-2 (Tra2) is expres-
sed almost ubiquitously in Drosophila adults, but
participates in the tissue-specific regulation of
splicing in several RNAs. In somatic tissues Tra2
participates in the activation of sex-specific splice
sites in doublesex and fruitless pre-mRNAs. In the
male germline it affects splicing of other transcripts
and represses removal of the M1 intron from its
own pre-mRNA. Here we test the hypothesis that the
germline specificity of M1 repression is determined
by tissue-specific differences in Tra2 concentration.
We find that Tra2 is expressed at higher levels in
primary spermatocytes of males than in other cell
types. Increased Tra2 expression in other tissues
reduces viability in a manner consistent with known
dose-dependent effects of excessive Tra2 expres-
sion in the male germline. Somatic cells were found
to be competent to repress M1 splicing if the level
of Tra2 transcription was raised above endogenous
concentrations. This suggests not only that M1
repression is restricted to the germline by a
difference in Tra2 transcription levels but also
that the protein’s threshold concentration for M1
regulation differs from that of doublesex and
fruitless RNAs. We propose that quantitative
differences in regulator expression can give rise to
cell-type-specific restrictions in splicing.
INTRODUCTION
Alternative pre-mRNA splicing is an important mechanism
affecting gene function. The utilization of alternative splice
sites is regulated by a variety of proteins that interact with
elements in the pre-mRNA to affect the function and/or
assembly of spliceosomal complexes on them. Perhaps the
best understood of these regulators come from the SR super-
family of splicing factors (1). Proteins from this family are
critical components in the earliest steps of constitutive splice
site recognition and often bind speciﬁcally near alternative
splice sites to favor their selection.
Transformer-2 (Tra2) is an SR superfamily protein requi-
red for sex-speciﬁc splicing in several mRNAs involved in
sexual differentiation in Drosophila (2). Mammalian ortho-
logues of Tra2 have been reported to affect alternative
splicing of a number of RNAs, including transcripts impli-
cated in breast cancer (3), neuropathies (4–9) and sexual
differentiation (10). The targets of Tra2 regulation appear
to be restricted by tissue type. Drosophila Tra2 is expressed
in most somatic tissues where it is required along with
Transformer (Tra) and other SR proteins to activate the
female-speciﬁc utilization of an alternative 30 splice site in
the doublesex pre-mRNA (11,12). This leads to the formation
of an mRNA encoding the Dsx-F protein which speciﬁes
female differentiation in these tissues. In the nervous system
Tra2 and Tra similarly direct female-speciﬁc utilization of an
alternative 50 splice site in fruitless pre-mRNA resulting in
sex-speciﬁc expression of Fruitless protein isoforms which
in turn specify sex-speciﬁc behaviors (13). A third function
of Tra2 is restricted to the male germline where it represses
removal of the M1 intron from its own pre-mRNA (14,15).
The presence of the intron prevents the translation of
functional Tra2 protein isoforms and thus splicing repression
serves as a negative feedback mechanism (16). This mecha-
nism affects a signiﬁcant fraction of germline Tra2 transcripts
where  50% retain the M1 intron in a manner dependent
on functional Tra2 protein. Studies on an altered tra2 gene
lacking the M1 intron indicate that its retention in these
RNAs prevents excess or inappropriate Tra2 expression that
would otherwise reduce fertility (17).
The mechanism by which M1 repression is restricted to
the male germline is not known. Tra2 is translated and
functions in a variety of somatic tissues in the adult, but
Tra2-dependent repression of M1 splicing does not occur
in these cells (18). Rather only a small fraction of Tra2
transcripts retain M1 and this intron retention is independent
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Tra2-dependent M1 retention requires additional germline-
speciﬁc splicing regulators but such factors have not yet
been identiﬁed. Moreover, nuclear extracts from somatically
derived Schneider 2 cells have been found to support Tra2-
dependent repression of M1 splicing (15). This suggests
that a germline-speciﬁc factor is not required for M1
repression.
Here we test an alternate hypothesis that the tissue speciﬁ-
city of M1 repression results from differences in Tra2
concentration levels in the soma and germline. This idea is
suggested by the observations that the highest levels of
Tra2 expression are found in adult spermatocytes and that
the fraction of M1 retaining RNA in these cells is highly sen-
sitive to gene dose (17). Our results support this hypothesis
and suggest that splicing factors are able to recognize differ-
ent sets of targets at different cellular concentration levels.
MATERIALS AND METHODS
Plasmid constructs
The plasmid pActTra2 was constructed by inserting a 533 nt
fragment containing the Actin5C distal promoter upstream of
a Tra2 cDNA insert encoding the Tra2-P2 (previously called
‘Tra2-226’) protein isoform. The plasmid pActTra2-Nae+1
was generated by using the same Actin promoter fragment
to replace the region upstream of the ApaI site in the plasmid
pTZ3.9A-ORF3 (18). This places the Actin promoter and
initiation site 23 nt upstream of the natural male germline
transcription start which is internal to exon 3. The plasmid
contains 3.7 kb of genomic sequences including all down-
stream tra2 exons and introns. The plasmid pUAS-MycTra2
was generated from the vector pTMW (Drosophila Genomic
Resource Center and T. D. Murphy, unpublished data) by
inserting a Tra2-P2 encoding cDNA at the translation start
codon to form an N-terminal fusion with a 6· Myc epitope
tag. We subsequently determined that the provided version
of this vector contains only two UAS elements. We therefore
replaced its UAS cassette with the equivalent region from
the plasmid pUAST which has ﬁve copies of the UAS (21).
Transfection of Schneider 2 cells
For each transfection, 1.0 · 10
6 cells were seeded in 100 mm
plates. Cells were transfected using the cellfectin reagent
(Invitrogen, CA) and a total of 20 mg plasmid DNA. The
DNA mixture included 5 mg of pTZ-Tra2Nae+1 in all
cases except where noted as well as 0, 1.5 or 5 mg of either
pSK-ActTra2 or pSK-ActbGal construct using cellfectin
reagent according to the manufacturer’s manual. Cells were
harvested 48 h after transfection for RNA preparation.
RNA isolation and RT–PCR
RNA from S2 cells was extracted using the Trizol reagent
(Invitrogen). Reverse transcription was performed using
Superscript-II reverse transcriptase (Invitrogen) and oli-
go(dT) primers on 20 mg total RNA. One-fourth of the
reverse transcription product was used for low-cycle
PCR with a sense primer from the Actin–Tra2 junction
(Act/T2·35 0-CTACCGTTTGAGGGCCCTTTC-30) and an
antisense primer overlapping the 7 nt insertion in exon
4( N a e +15 0-GACCGCTGGTGCCGATCCCCG-30). PCR
conditions were 5 min at 94 C, followed by 20 cycles, each
consists of 30 sec at 94 C, 60 sec at 58 C and 60 sec at 72 C,
with a ﬁnal extension for 10 min. To detect PCR products,10
ml of the ampliﬁcation was separated on a 1% agarose gel,
blotted and hybridized with a
32P kinase-labeled oligonu-
cleotide X3-1182 (50-ACCCGATTTCATTTCATTGGAAG-
30) in the Rapid-Hyb buffer (Amersham Biosciences). The
blots were exposed to a phosphoimager screen and Kodak
1-D software was used to quantify the data.
RNA from adult ﬂies was produced by collecting 50–100
females as described previously (16). Ampliﬁcation of
endogenous RNA from Drosophila adults was carried out
using a procedure similar to that described above except
that a sense primer from within exon 3 (X3S, 50-CTCAG-
CCGATTCAGCTGGTGCTCTTG) and an antisense primer
from the exon 5/6 junction (X5/X6, 50-CGCTGTGTTTG-
TGCGTCAATCA) were used. To detect products the blot
was probed with a
32P kinase-labeled oligonucleotide
from exon 4 (Nae WT, 50-TGGTGCCG GCGACTG).
Fly crosses
Transgenic ﬂies were generated by P element mediated
germline transformation (22). The plasmid pUAS-MycTra2
was injected directly into Drosophila embryos of the geno-
type w
1118/B
sY; tra2
b/CyO. Transformed lines were identiﬁed
in the G1 progeny of injectees by w
+ eye pigmentation. Once
established these strains were crossed with various GAL4
strains and adult progeny recovered at 23 or 25 C. Heat-
shock induction was carried out at 37 C for 1 h by immersing
vials in a water bath. Viability of adults carrying both Gal4
and UAS transgenes was measured by counting adult pro-
geny. Percent viabilities are given in relation to the recovery
of siblings of other genotypes and expected Mendelian ratios.
Rescue of viability by loss-of-function tra2 mutations
was determined by crossing w
1118/Y; Bl tra2
1/+;P { w
+mC,
GAL4-Hsp70.PB} 89-2-1/+ males with y
1 w
67c23;P { w
+,
UAS-MycTra2}, tra2
b/CyO, P{Ubi-GFP.S65T} (Line 1)
females. Clones of cells expressing MycTra2 were produced
by crossing w
1118/Y; P{w
+, UAS-MycTra2}, tra2
b/CyO;
P{w
+, CZP-ORF3} males with females of the genotype
P{hs-FLP}; P{w
+mC,AyGAL4}, P{UAS-eGFP}. Progeny
were subjected to 37 C heat shock for 30 min at between
24 and 36 h of development. This induced FLP recombinase
expression and the formation of random GAL4 expressing
clones by excision of the FRT ﬂanked yellow gene which
separates the Actin 5C promoter from GAL4 coding
sequences in P{AyGAL4}. Other ﬂy strains were obtained
from the Bloomington Drosophila Stock Center.
Western blot and immunofluorescent staining of
larval tissues
Western blots were carried out with a 1:1000 dilution the
mouse anti-Myc antibody 9E10 (Santa Cruz) at 4 C
overnight. The secondary antibody was a 1:1000 dilution
HRP-conjugated goat anti-mouse IgG (Pierce Biotechnology,
Inc.), incubated at room temperature for 1 h. Immunoﬂuores-
cent staining of larvae was carried out after sorting males
and females at third instar stage. These were dissected and
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ton X-100). The primary antibodies were mouse anti-GFP
and rabbit anti-b-galactosidase (Molecular Probes), used at
1:300 dilution at 4 C overnight. The secondary antibodies
were goat anti-mouse IgG Alexa ﬂuor 488 and goat anti-
moust IgG Alexa ﬂuor 546 (Molecular Probes), incubated
at 1:100 dilution at room temperature for 2 h. Samples
were mounted with Vectashield and observed under a Zeiss
LSM 510 confocal microscope.
RESULTS
M1 retention is induced by increased Tra2
expression in Schneider 2 cells
It has previously been shown that in vitro splicing of the
M1 intron in Schneider 2 (S2) cell nuclear extracts is
repressed by the addition of recombinant Tra2 protein (15).
Because this line of cells is thought to be of somatic origin
(23), we investigated whether a similar Tra2-dependent effect
on M1 splicing could be observed in vivo by transfection.
Transfection experiments were carried out using two different
plasmids in which Tra2 transcripts are driven by the Actin 5C
promoter. pActTra2 which contains a Tra2 cDNA encoding
the Tra2 protein isoform Tra2-P2 (Figure 1A) serves as the
primary source of Tra2 protein. This isoform is normally
expressed in both the soma and male germline and is
known to be sufﬁcient for M1 repression in the germline.
The second plasmid pActTra2Nae+1 contains genomic
coding sequences altered by a 7 nt insertion introduced into
exon 4. This small insertion causes a shift in reading frame,
disrupting expression of all Tra2 protein isoforms competent
for repression of M1 (18). Importantly, this insertion
also allows the reporter transcripts to be distinguished
from those of pActTra2 and the endogenous tra2 gene in
RT–PCR assays. The Actin 5C promoter in pActTra2-
Nae+1 is positioned to initiate transcription in exon 3 because
this is the position of the transcription start site used in
endogenous male germline transcripts. When no Tra2
expressing plasmid was introduced, only 8% of the reporter
transcripts retained the M1 intron (Figure 1B, lane 4). This
fraction increased to as much as 36% with increasing
amounts of co-transfected pActTra2 (Figure 1B, lanes 6 and
8). The effects are speciﬁc to the Tra2 protein as a plasmid
driving b-galactosidase from the same actin promoter
pActbGal had no effect on M1 retention in the reporter
RNA (Figure 1B, lanes 10 and 12). Together these results
indicate that Tra2-dependent splicing repression is supported
by cultured cells of somatic origin.
The Tra2 promoter is most active in the male germline
Based on the above results we hypothesized that the
germline restriction of M1 repression in male ﬂies does not
require tissue-speciﬁc splicing regulators but rather that
higher levels of Tra2 in this tissue are responsible. Speciﬁc
antibodies for the Tra2 protein are not available so to estimate
the relative level of its expression in the male germline and
other tissues we examined a tra2 reporter (C-lacZ), which
contains tra2 genomic sequences fused with the Escherichia
coli b-galactosidase gene at the C-terminal end of Tra2
protein-coding region (24). This transgene contains all
required upstream regulatory sequences from the tra2 gene
including both the somatic and male germline promoters.
It has been shown to robustly rescue somatic female sexual
differentiation, suggesting that it produces protein at or
above normal endogenous levels. Tra2 is expressed in most
tissues of both male and female adults (12), but as shown
in Figure 2A, testes from ﬂies carrying the transgene stained
more strongly with X-gal than did other male tissues indicat-
ing that the highest levels of protein are expressed there.
Within the testis, X-gal staining was most concentrated
in primary spermatocytes where Tra2 function is required
(Figure 2B) (25). To more quantitatively determine the extent
of this difference in expression, we prepared extracts from
dissected testes and carcasses of adult males and measured
b-galactosidase activity levels in relation to total protein
concentration. As shown in Figure 2C, the speciﬁc activity
in testes was found to be over 14 times higher than that
in the remaining carcass. The above results conﬁrm that
Tra2 expression is signiﬁcantly higher in the germline than
in other tissues and are consistent with previous direct
comparisons of mRNA levels in wild-type and germline-
deﬁcient ﬂies (12,26).
Increased Tra2 expression through the Gal4-UAS
system reduces viability
To test whether an increase in Tra2 protein outside the
male germline would stimulate retention of the M1 intron
Figure 1. Drosophila S2 cells support Tra2 induced M1 retention. (A)
A schematic diagram of the M1 splicing reporter pActTra2-Nae+1 is shown.
The unfilled boxes indicate exons and the solid lines indicate introns deriving
from the tra2 gene. The grey box indicates promoter sequences from the
Actin 5C. The position of the predicted transcription start site is indicated
(arrow). The position of the fusion of actin sequences with exon 3 is nearly
coincident with the natural male germline transcription start site. The position
of the 7 nt insertion in exon 4 used to disrupt translation is also indicated by
a triangle. The positions of primers used for RT–PCR experiments are shown
as arrowheads. (B) RT–PCR results on the M1 splicing reporter in transfected
S2 cells. For each sample, both reaction with (+) and without ( ) reverse
transcriptase (RT) are shown. The amount of M1 retention is indicated below
the gel lanes. The amount (micrograms) of pActTra2, pActbGal and
pActTra2-Nae+1 (reporter) used in each transfection are indicated above
the gel. The total amount of DNA used in each transfection was kept constant
at 20 mg using empty vector plasmid for the balance. The PCR products of
M1 retaining and M1-spliced forms are indicated with diagrams on the side.
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expression of proteins under the control of inducible and
tissue-speciﬁc drivers (21). A P element based plasmid was
constructed with a cDNA encoding the Tra2-P2 protein pre-
ceded by UAS elements and an in-frame N-terminal repeat of
six Myc epitope tags (Figure 3A). This construct UAS-
MycTra2 was then introduced into the ﬂy genome by P ele-
ment mediated transformation. Three insertions of this trans-
gene were obtained at independent sites and used to produce
stable stocks.
As an initial test of the function of UAS-MycTra2
transgene insertions, we crossed each strain to various driver
strains expressing yeast GAL4 with different tissue distribu-
tions (Table 1). However, adult ﬂies carrying the combination
of GAL4 and UAS-MycTra2 transgenes were not recovered
in these crosses due to lethality at earlier developmental
stages. To overcome this, we generated ﬂies in which Tra2
expression was driven by the heat-inducible heat shock
protein 70 (hsp70) promoter which is active at a low level
in a wide variety of somatic tissues even when ﬂies are
cultured at 23 C without heat shock. This low level of
GAL4 activity allowed us to recover from 41 to 70% of
the expected individuals carrying both hsp70-Gal4 and
UAS-MycTra2 as viable adults (Table 1). The number of
survivors was diminished to <1% when ﬂies were subjected
to heat shock at various times during larval development.
Figure 2. Tra2 is expressed at highest levels in the germline of male adults.
Expression monitored using a b-galactosidase reporter transgene (C-lacZ)
under the control of the tra2 promoter is shown. (A) Shows X-gal staining of
testes (t) in comparison to malphigian tubules (mt), accessory glands (ac) and
gut (g). A closeup view of the testis showing indicating staining of primary
spermatocytes (bracket) is shown in (B). (C) Shows results from quantitative
determination of b-galactosidase activity in extracts from various testes (T)
and remaining carcass (C) in both normal w
1118 male adults (control) and
transgenic flies carrying the reporter in the same genetic background.
Standard errors are indicated by the lines.
Table 1. Viability of adults expressing UAS-MycTra2
GAL4 driver
line
Tissues UAS-MycTra2
line
Adult viability
(%)
None 1 91
29 4
39 8
Actin 5C Ubiquitous 1 0
20
30
T76 Imaginal discs, testes, CNS 2 0
T80 Imaginal discs, gonads, CNS 1 0
20
30
Hsp70 Ubiquitous 1 (23 C) 41
1 (hs) 1
2 (23 C) 70
2 (hs) 0
3 (23 C) 48
3 (hs) 1
Figure 3. Increased expression of Tra2 under control of the hsp70 promoter
reduces viability. A schematic diagram of the UAS-MycTra2 transgene is
shown (A). The position of the 6·Myc tag at the protein’s N-terminus and the
position of five UAS elements is indicated. The arrow indicates the position
expected for transcription initiation. Not shown are P element sequences from
the transformation vector. When anti-Myc antibodies are used to probe a
western blot on extracts (B) from female adults carrying the hsp70-Gal4
transgene and any of three UAS-MycTra2 insertions, a prominent band is
observed at the expected size for the fusion protein ( 48 kDa). This protein is
not present extracts of non-transgenic control females (nt). Lower molecular
weight proteins (X) are also observed in transgenics and may represent
degradation products or alternate initiations within the 6·Myc tag. Extracts
prepared after heat shock and recovery have sharply increased levels of Myc-
Tra2. As a loading control, the same blot was probed with an antibody against
Drosophila drICE. (C) Shows that viability at 25  is reduced in flies carrying
both hsp70-Gal4 and UAS-MycTra2 (line 1) as measured in relation to their
siblings. Homozygosity for a tra2 loss-of-function mutation (tra2
b) causes a
slight reduction in measured viability of control flies (UAS-MycTra2), but the
same mutation increases viability of flies driving expression from hsp70-Gal4
(P < 0.0001).
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without heat shock conﬁrmed that they express a protein
product of the expected size for the MycTra2 fusion
protein (Figure 3B). A small amount of another product
detected speciﬁcally in transgenic ﬂies migrated at a smaller
size. This may be either a product of proteolysis or due to
translation initiation from one of several AUG initiation
codons within the Myc tag repeats near the protein’s
N-terminus. In either case, the levels of functional MycTra2
expression were sufﬁcient to partially rescue sexual differen-
tiation defects in the soma of diplo-X (chromosomally
female) individuals homozygous for a tra2 loss-of-function
mutation as indicated by feminization of their genitalia, leg
bristles and abdominal pigmentation (data not shown).
Thus, the MycTra2 protein is functional in the soma.
Even when expressed from the hsp70-GAL4 driver at 23 C
UAS-MycTra2 caused some reduction in viability relative to
Mendelian expectations (Table 1). Such lethality might
result either from an excess of protein in tissues where it is
normally expressed or from an aberrant activity conferred
by the Myc tag. In the former case we would expect that
viability would be improved if Tra2 expression from the
endogenous gene was reduced in transgenic ﬂies. Consistent
with this we observed that transgenic individuals homozy-
gous for a tra2 loss-of-function mutation were signiﬁcantly
more viable (P < 0.0001) than their tra2
+ siblings
(Figure 3C). We conclude that excess Tra2 is deleterious to
survival.
Somatic tissues are competent to carry out
Tra2-dependent M1 repression
To determine if increased levels of Tra2 lead to M1 repres-
sion in transcripts expressed outside of the male germline
we examined M1 splicing in endogenous tra2 transcripts
isolated from females expressing MycTra2. We allowed
diplo-X ﬂies carrying both hsp70-GAL4 and UAS-MycTra2
to develop without heat induction and then isolated RNA
after subjecting them to a brief heat shock as adults. Somatic
tissues produced a low level of endogenous RNA retaining
the M1 intron; however, this retention occurs independently
of the Tra2 protein and may reﬂect transcripts that have sim-
ply not completed processing (20). As shown in Figure 4, the
basal levels of MycTra2 expressed without heat shock caused
a small increase in the fraction of RNA retaining the M1
intron. As expected heat shock increased MycTra2 expression
dramatically (Figure 3B) and further increased M1 reten-
tion from the endogenous Tra2 gene (Figure 4). In these
experiments we also observed a small heat-shock-induced
increase in M1 retention in individuals without the transgene.
The latter effect is presumably due to disruption of RNA
splicing by heat-shock conditions. In summary, these results
indicate that the expression of Tra2 at high levels outside
the male germline results in ectopic M1 intron retention.
To verify that M1 repression occurs when Tra2 levels
are increased in a speciﬁc somatic tissue, we next genera-
ted clones of cells overexpressing MycTra2 in larval
imaginal discs and monitored M1 splicing levels using
a splicing reporter transgene CZP-ORF3 that expresses
b-galactosidase only from transcripts containing the intron
(18). Patches of clonally derived somatic cells expressing
Gal4 were generated using a strategy in which heat-
shock-induced expression of FLP recombinase causes the
ubiquitously active Actin 5C promoter to fuse with Gal4-
coding sequences in random cells during development
(see Materials and Methods for details). The Gal4 expressing
cells were detected by activation of a UAS-GFP transgene
that was carried by the same ﬂies as a marker. As shown in
Figure 5, GFP-positive cells that also express MycTra2 had
signiﬁcantly elevated levels of b-galactosidase expression in
relation to other cells in the same disc (see arrows in panels
D and E) which did not have an activated Gal4 gene and
therefore did not express GFP or MycTra2. These results
indicate that the induction of MycTra2 expression leads to
an increase in M1 intron retention. Control assays which
lacked the reporter transgene or the b-galactosidase primary
antibody showed no such signal in the GFP-positive cells
(data not shown).
DISCUSSION
A number of known RNA splicing regulators have been
shown to be widely expressed within organisms but to vary
spatiotemporally in concentration (10,27–33). In some cases
qualitative differences in alternative splicing can be elicited
by manipulating the levels of such factors either in vitro or
in vivo. This suggests that natural quantitative variations in
expression levels have functional signiﬁcance. For instance,
the selection of alternative splice sites in several genes is
sensitive to the amount of the SR protein SF2/ASF in
relation to hnRNP A1 (28,34–36). Likewise, artiﬁcially
increased expression of several splicing factors in Drosophila
transgenic strains has been shown to affect the splicing
of speciﬁc RNAs or the viability and development of the
organism (28,34–37). Such observations suggest the possibil-
ity that there are threshold concentrations in vivo at which
such factors become able to inﬂuence the splicing of different
RNA targets.
The studies presented here argue that a threshold exists
in the amount of Tra2 that is required for repression of
M1 splicing and that somatic levels of Tra2 expression
are below the threshold required for M1 repression while
levels in the germline exceed it. Tra2 RNA is expressed in
% M1
retention
RT
strain line 1 line 2 nt
32 87 78
+ –+ –+ –
19 27 28
line 1 line 2 nt
+ –+ –+ –
unspliced
spliced
no heat shock after heat shock
Figure 4. Increased Tra2 expression in females results in increased M1
retention. Low cycle RT–PCR analysis of M1 splicing in non-transgenic (nt)
female adults and females carrying both hsp70-Gal4 and either of two
UAS-MycTra2 insertions (lines 1 and 2) are shown. The percent of products
with the M1 intron retained is indicated below the gel. The level of M1
retention is increased slightly without heat shock and more dramatically after
heat shock and recovery. Reactions were performed both with (+) and without
( ) reverse transcriptase. RNA samples are from the same individuals used
for the western blot in Figure 3B.
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soma than in the male germline (12,18). Analysis of steady-
state Tra2 transcript levels indicates that over half of all Tra2
RNA in adult males derives from the germline being most
concentrated in primary spermatocytes. The remaining half
of the mRNA is distributed in a relatively large number of
cells in a variety of somatic tissues that undergo and maintain
sexual differentiation. An analysis of Tra2 proteins expressed
in wild-type and mutant ﬂies also suggests that levels of Tra2
in the testes are higher than in the soma (38). These observa-
tions are further supported by our analysis of transgenic ﬂies
expressing a Tra2/b-galactosidase fusion protein under
direction of the tra2 promoter and other ﬂanking regions.
In these experiments we observed fusion protein expression
in a number of different somatic tissues but in all cases at a
signiﬁcantly lower level than that found in spermatocytes.
Moreover, the relative cellular concentration of fusion protein
(as measured in relation to total protein) is several fold higher
in the testis than in the soma. Interestingly, the human
Tra2b protein has also recently been reported to be most
prominently expressed in testes where it regulates the male
germline-speciﬁc inclusion of the T exon of the HipK3
gene in a concentration dependent manner (10).
Although it is expressed at lower levels, Tra2 has
clear effects on RNA splicing in somatic tissues where it
acts with Tra and other SR factors to direct selection of
female-speciﬁc alternative splice sites within the dsx and
fru mRNAs (11,13,39,40). Strong tra2 loss-of-function muta-
tions result in selection of the alternative male-speciﬁc dsx
and fru splice sites indicating that Tra2 is required in most
or all tissues where these RNAs are produced. We propose
that these RNAs must have a lower threshold concentration
at which Tra2 is able to interact with them than does M1.
Consistent with this idea, we found that increasing the level
of Tra2 expression induced M1 retention in somatic tissues.
These cells are thus able to support Tra2-dependent repres-
sion of the intron’s splicing provided sufﬁcient levels of
Tra2 protein are present. These results explain why Tra2 is
observed to speciﬁcally repress M1 splicing in extracts
derived from Drosophila S2 cells after they are supplemented
with recombinant protein (15).
The difference in Tra2 levels needed for the repression
of M1 splicing versus those needed to activate splice sites
in dsx and fru seems likely to reﬂect differences in the afﬁnity
of the protein for its RNA target. In the case of dsx and fru,
Tra2 interacts with an exonic splicing enhancer and behaves
as a splicing activator (40–42). In the M1 intron Tra2 binds
instead to an intronic splicing silencer (ISS) and interferes
with early steps in spliceosome assembly [(15), J. Qi,
S. Su, and W. Mattox, manuscript submitted]. In the dsx
splicing enhancer binding of Tra2 is facilitated by coopera-
tive interactions with other SR proteins such as Tra and
Myc-Tra2
yellow+
Gal4
Actin 5C
promoter
FRT FRT
Gal4
Actin 5C
promoter
FRT
FLP  recombinase
(heat shock induced)
GFP
clones of cells expressing
 GFP and Myc-Tra2
UAS
UAS
AU AUG
lacZ
frameshift
M1
G
CZP-ORF3 (M1 reporter)
B
F
C
D
A
E
G
Figure 5. M1 retention in Drosophila somatic tissues expressing UAS-MycTra2. (A) A schematic diagram is shown of the strategy for producing Tra2
overexpressing clones. Induced expression of yeast FLP recombinase from a FLP transgene driven by the hsp70 promoter causes fusion of ubitquitously active
actin 5C promoter with Gal4 coding sequences in random cells. Clones of GAL4 positive cells are detected by activation of UAS-GFP and also express UAS-
MycTra2. These clones were generated in flies also carrying a Tra2-b-galactosidase reporter transgene (CZP-ORF3) which produces RNA ubiquitously, but only
expresses b-galactosidase if the M1 intron is retained. The reporter contains a frameshift mutation blocking translation from open reading frames used when the
M1 intron is removed and initiating in exons 2 or 3. Expression of the reporter protein in intron-retaining RNA results from translation initiation at an AUG codon
located downstream of M1 in exon 4. Shown are results from whole mount immunofluorescent staining of a larval imaginal disc (B, D and F) or brain tissue (C,
E and G) that include clones of cells overexpressing UAS-MycTra2. Green staining (GFP) marks cells in which UAS-Myc-Tra2 is activated by Gal4 (B and C)
and Red staining (b-galactosidase) marks cells with increased M1 retention (D and E). A merge of the red and green channels is also shown (F and G). Arrows in
(D and E) indicate examples of large areas where GAL4 and Myc-Tra2 are not expressed and the reporter is not induced. Note that GFP staining is cytoplasmic
and the Tra2-b-galactosidase fusion protein from the reporter is nuclear.
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ISS differ from those identiﬁed in the dsx splicing enhancer
and similar cooperative interactions have not been observed
(15). Thus, the threshold at which an RNA responds to
Tra2 may be determined by arrangement and sequence of
the regulatory elements within each RNA.
As feedback regulation through M1 splicing is simply
a means of limiting Tra2 expression, it does not in of itself
account for why expression is higher in the germline. It
seems likely that the higher levels of Tra2 present in the
germline are required for fertility, but this has not been rigor-
ously tested. Other genes producing alternatively processed
pre-mRNAs in the germline are known to be Tra2 dependent
(16) and it is possible that these targets, similar to the
M1 intron, require a relatively high level of Tra2 for proper
processing.
In agreement with our ﬁndings in the soma, in vivo studies
on M1 splicing in the male germline previously indicated that
the extent of M1 repression is highly dependent on the level
of Tra2 present there (17). For instance males heterozygous
for a point mutation disrupting the protein-coding region
produce a smaller fraction of germline M1 retaining RNA
than do males with two wild-type alleles. The dose sensitivity
of M1 splicing and its relatively high threshold seems logical
in view of the known role for M1 splicing repression in the
negative feedback regulation of Tra2. In normal ﬂies over
half of all germline transcripts retain the intron in wild-type
individuals (18). This prevents excessive expression of the
protein that would result if the intron were removed from
all endogenous germline transcripts (17,38). Although it is
presently unclear why such an excess of transcripts is
produced it appears that regulatory elements in the intron
are ‘calibrated’ to undergo repression when the concentration
of Tra2 protein approaches deleterious levels.
Beyond the observed effects on M1 splicing, we found that
artiﬁcially increasing somatic Tra2 expression had negative
effects on viability. This may indicate that inappropriate
concentrations of Tra2 alter the splicing pattern of additional
somatic RNAs which are important for the survival of the
organism. Similar observations have been made after overex-
pression of the splicing factors B52 and FNE (28,43). Thus
concentration may have a vital role in determining the targets
that are affected by multiple splicing regulators. This dose-
sensitive behavior of splicing regulators is not universal as
some have been reported to have little or no signiﬁcant
adverse effects when overexpressed (44,45). As in the germ-
line, negative feedback regulation of Tra2 through
M1 splicing potentially provides a mechanism for the ﬂy to
curb deleterious effects if a natural circumstance occurred
in which excessive Tra2 transcripts were produced. However,
normal endogenous levels of expression do not lead to
Tra2-dependent M1 retention in any of several somatic
tissues we have examined so far.
The ability of Tra2 to induce qualitatively different effects
on alternative splicing at different concentration levels in the
soma is interesting in light of the large number of transcripts
now known to undergo alternative splicing in complex organ-
isms (46) and the relatively small number of known splicing
regulators. It is already clear that SR proteins and other
factors can control the processing of multiple pre-mRNA
targets. By activating or repressing different splice sites at
different concentration levels, such regulators are likely to
expand the diversity of tissue-speciﬁc splicing patterns that
they can specify.
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